Small vessel vasculitis of the lung

Thorax

Volumn 55, Issue 6, 2000, Pages 502-510

  Schwarz, Marvin I ^a   Brown, Kevin K ^a  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; COTRIFAMOLE; CYCLOPHOSPHAMIDE; MEPREDNISONE; MESNA; METHOTREXATE; PREDNISONE;

HEMORRHAGIC CYSTITIS; HUMAN; IMMUNOPATHOLOGY; LUNG BLOOD VESSEL; PNEUMONIA; PRIORITY JOURNAL; REVIEW; THORAX RADIOGRAPHY; VASCULITIS; WEGENER GRANULOMATOSIS;

ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; APOPTOSIS; BRONCHOALVEOLAR LAVAGE FLUID; CAPILLARIES; COLLAGEN DISEASES; HEMORRHAGE; HUMANS; LUNG; LUNG DISEASES; VASCULITIS; WEGENER GRANULOMATOSIS;

EID: 0034124580     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thorax.55.6.502     Document Type: Review

References (161)

1. 1 Schwarz MI. The non-granulomatous vasculitides of the lung. Semin Respir Crit Care Med 1998;19:47-56.
2. 2 Schwarz MI. Diffuse alveolar hemorrhage. In: Schwarz MI, King TE, eds. Interstitial lung disease. 3rd ed. Hamilton: BC Decker Inc, 1998: 535-8.
3. 3 Schwarz MI, Cherniack RM, King TE. Diffuse alveolar hemorrhage and other rare infiltrative disorders. In: Murray JR, Nadel JA, eds. Respiratory medicine, 2nd ed, WB Saunders: Philadelphia, 1993: 1889-912.
4. 4 Schwarz MI. Pulmonary capillaritis. Pulm Perspect 1994;11: 4-6.
5. 5 Spencer H. Pulmonary lesions in polyarteritis nodosa. Br J Tuberc Dis Chest 1957;51:123-30.
6. 6 Mark EJ, Ramirez JF. Pulmonary capillaritis and hemorrhage in patients with systemic vasculitis. Arch Pathol Lab Med 1985;109:413-8.
7. 7 Travis WD, Colby TV, Lombard C, et al. A clinicopathologic study of 34 cases of diffuse pulmonary hemorrhage with lung biopsy conformation. Am J Surg 1990;14: 1112-25.
8. 8 Katzenstein ALA, Askin FA. Miscellaneous pulmonary angiitides. In: Surgical pathology of non-neoplastic lung disease. Philadelphia: WB Saunders, 1990: 282-5.
9. 9 Schwarz MI, Mortenson RL, Colby TV, et al. Pulmonary capillaritis: the association with progressive irreversible air-flow limitation and hyperinflation. Am Rev Respir Dis 1993; 148:507-11.
10. 10 Bruglere O, Raffy O, Sleiman C, et al. Progressive obstructive lung disease associated with microscopic polyangiitis. Am J Respir Crit Care Med 1997;155:739-42.
11. 11 Jennings CA, King TE Jr, Tuder R, et al. Diffuse alveolar hemorrhage with underlying isolated pauciimmune pulmonary capillaritis. Am J Respir Crit Care Med 1997;155: 1101-9.
12. 12 Bosch X, Lopez-Soto A, Mirapeix E, et al. Antineutrophil cytoplasmic antibody-associated alveolar capillaritis in patients presenting with pulmonary hemorrhage. Arch Pathol Lab Med 1994;118:517-22.
13. 13 Bosch X, Font J, Mirapeix E, et al. Antimyeloperoxidase autoantibody-associated necrotizing alveolar capillaritis. Am Rev Respir Dis 1992;146:1326-9.
14. 14 Nierman DM, Kalbt H, Ornstein MH, et al. A patient with antineutrophil cytoplasmic antibody-negative pulmonary capillaritis and circulating primed neutrophils. Arthritis Rheum 1995;38:1855-8.
15. 15 Dhillon SS, Singh D, Doe M, et al. Diffuse alveolar hemorrhage and pulmonary capillaritis due to propylthiouracil. Chest 1999;116:485-8.
16. 16 Nicolls MR, Terada L, Tuder RM, et al. Diffuse alveolar hemorrhage and pulmonary capillaritis in the retinoic acid syndrome. Am J Respir Crit Care Med 1998;158:1302-5.
17. 17 Green RJ, Ruoss SJ, Kraft SA, et al. Pulmonary capillaritis and alveolar hemorrhage: update in diagnosis and management. Chest 1996;110:1305-16.
18. 18 Leatherman JW. The lung in systemic vasculitis. Semin Respir Infect 1988;3:274-88.
19. 19 Leatherman JW. Immune alveolar hemorrhage. Chest 1987; 91:891-7.
20. 20 Martinez AJ, Maltby JD, Hurdst DJ. Thrombotic thrombocytopenic purpura seen as pulmonary hemorrhage. Arch Intern Med 1983;143:1818-20.
21. 21 Golde MJ. Occult pulmonary hemorrhage in leukemia. BMJ 1975;2: 166-8.
22. 22 Fireman Z, Yust I, Abramov CC. Lethal occult pulmonary hemorrhage in drug-induced thrombocytopenia. Chest 1981;79:358-9.
23. 23 Gertner E, Lie JT. Pulmonary capillaritis, alveolar hemorrhage and recurrent microvascular thrombosis in primary antiphospholipid syndrome. J Rheumatol 1993;20:1224-8.
24. 24 Crausman RS, Achenback GA, Pluss WT, et al. Pulmonary capillaritis and alveolar hemorrhage associated with the antiphospholipid syndrome. J Rheumatol 1995;22:554-6.
25. 25 Leatherman JW, Davies SF, Hoidal JR. Alveolar hemorrhage syndromes: diffuse microvascular lung hemorrhage: an immune and idiopathic disorder. Medicine 1984;63:343-61.
26. 26 Beechler CR, Enquist RW, Hunt RR, et al. Immunofluorescence of transbronchial lung biopsies in Goodpasture's syndrome. Am Rev Respir Dis 1980;121:869-72.
27. 27 Matthew TH, Hobbs JB, Kalowski S, et al. Normal renal diagnostic findings in Goodpasture's syndrome. Ann Intern Med 1975;82:215-8.
28. 28 Abboud RT, Chase WH, Ballon HS, et al. Goodpasture's syndrome: diagnosed by transbronchial biopsy. Ann Intern Med 1978;89:635-8.
29. 29 Zimmerman CM, Varanasi VR, Hoff B. Goodpasture's syndrome with normal renal function. Am J Med 1979;66: 163-71.
30. 30 Carre PH, Lloveras JJ, Didier A, et al. Goodpasture's syndrome with normal renal function. Eur Respir J 1989;2:911-5.
31. 31 Hamm H, Niedermeyer J, Krause J, et al. Antibasement membrane antibody disease of the lungs without renal involvement. Dtsch Med Wochenschr 1992;117:858-62.
32. 32 Tobler A, Schurch E, Altermatt HJ, et al. Antibasement membrane antibody with severe pulmonary hemorrhage and normal renal function. Thorax 1991;46:68-70.
33. 33 Ekholdt PF, Gulsvik A, Digranes S, et al. Recurrent diffuse pulmonary hemorrhage with minor kidney lesions. Eur Respir J 1985;66:353-9.
34. 34 Zamora MR, Warner ML, Tuder R, et al. Diffuse alveolar hemorrhage and systemic lupus erthematosus (SLE): clinical presentation, histology, survival and outcome. Medicine 1997;76:192-202.
35. 35 Elliot ML, Kuhn C. Idiopathic pulmonary hemosiderosis: ultrastructural abnormaliities in the capillary walls. Am Rev Respir Dis 1970;102:895-904.
36. 36 Myers JL, Katzenstein ALA. Microangiitis in lupus-induced pulmonary hemorrhage. Am J Clin Pathol 1986;85:552-6.
37. 37 Abud-Mendoza C, Diaz-Jouanene E, Alarcon-Segovia D. Fatal pulmonary hemorrhage in systemic lupus erythematosus: occurrence without hemoptysis. J Rheumatol 1985;12:558-61.
38. 38 Byrd RB, Trunk G. Systemic lupus erythematosus presenting as pulmonary hemosiderosis. Chest 1973;64:128-9.
39. 39 Gould DB, Soriano RZ. Acute alveolar hemorrhage in lupus erythematosus. Ann Intern Med 1975;83:836-7.
40. 40 Rodriquez-Iturbe B, Garcia R, Rubio L, et al. Immunohistologic findings in the lung in systemic lupus erythematosus. Arch Pathol Lab Med 1977;101:342-4.
41. 41 Kathuria S, Cheifec G. Fatal pulmonary Henoch-Schonlein purpura. Chest 1982;82:654-6.
42. 42 Churg A, Franklin W, Chan KL, et al. Pulmonary hemorrhage and immune complex deposition in the lung: complications in a patient with systemic lupus crythematosus. Arch Pathol Lab Med 1980;104:388-91.
43. 43 Markus HS, Clark JV. Pulmonary hemorrhage in Henoch-Schonlein purpura. Thorax 1989;44:525-6.
44. 44 Kauffmann RH, Hermann WA, Meyer CJ, et al. Circulating IgA-immune complexes in Henoch-Schonlein purpura: a longitudinal study of their relationship to disease activity and vascular deposition of IgA. Am J Med 1980;69: 859-66.
45. 45 Baart de La Falk-Ruyper EH, Kater L, Kuijten RH, et al. IgA deposits in cutaneous blood vessel walls and mesangium in Henoch-Schonlein purpura. Lancet 1973;i: 892-3.
46. 46 Levinsky R, Barrat T. IgA immune complexes in Henoch-Schonlein purpura. Lancet 1979;ii: 1100-3.
47. 47 Shichira M, Tsutsumi K, Yamamoto I, et al. Diffuse intrapulmonary hemorrhage and renal failure in adult Henoch-Schonlein purpura. Am J Nephrol 1987;7:140-2.
48. 48 Savige JA, Gallicchio M, Chang L, et al. Autoantibodies in systemic vasculitis. Aust NZ J Med 1991;21:433-7.
49. 40 Hoffman GS, Kerr GS, Leavitt RY, et al. Wegener's granulomatosis: an analysis of 158 patients. Ann Intern Med 1992;116a: 488-98.
50. 50 Bindi P, Mougenot B, Mentre F, et al. Necrotizing crescentic glomerulonephritis without significant immune deposits: a clinical and serological study. Q J Med 1993;86: 55-68.
51. 51 Gross WL, Luderman G, Krefer G, et al. Anticytoplasmic antibodies in Wegener's granulomatosis. Lancet 1986;i: 806.
52. 52 Andrasy K, Koderisch J, Waldherr R, et al. Diagnostic significance of anticytoplasmic antibodies (ACPA/ANCA) in detection of Wegener's granulomatosis and other forms of systemic vasculitis. Nephron 1988;49:257-8.
53. 53 Falk RJ, Jennette JC. Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis. N Engl J Med 1988;318:1651-7.
54. 54 Goeken JA. Antineutrophil cytoplasmic antibody: a useful serologic marker for vasculitis. J Clin Immunol 1991;2:161-74.
55. 55 Walters MDS, Savage COS, Dillon MR, et al. Antineutrophil cytoplasm antibody in crescentic glomerulonephritis. Arch Dis Child 1988;63:814-7.
56. 56 Lai RS, Lin SL, Lai NS, et al. Churg-Strauss syndrome presenting with pulmonary capillaritis and diffuse alveolar hemorrhage. Scand J Rheumatol 1998;27:230-2.
57. 57 Falk RJ, Terrell RS, Charles LA, et al. Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro. Proc Natl Acad Sci USA 1990;87:4115-9.
58. 58 Jennette JC, Falk RJ. Pathogenic potential of anti-neutrophil cytoplasmic antibodies. In: Gross WL, ed. ANCA associated vasculitides: immunological and clinical aspects. New York: Plenum Press, 1993:7-15.
59. 59 Groff WL, Schmitt WH, Scernok E. ANCA and associated diseases: immunodiagnositc and pathogenetic aspects. Clin Exp Immunol 1993;41:1-12.
60. 60 Badesch DB, Zamora MR, Fullerton D, et al. Pulmonary capillaritis: a possible histologic form of acute pulmonary allograft rejection. J Heart Lung Transplant 1998;17:415-22.
61. 61 Schwarz MI, Sutarik JM, Nick JA, et al. Pulmonary capillaritis and diffuse alveolar hemorrhage: a primary manifestation of polymyositis. Am J Respir Crit Care Med 1995;151:2037-40.
62. 62 Schwarz MI, Zamora MR, Hodges TN, et al. Isolated pulmonary capillaritis and diffuse alveolar hemorrhage in rheumatoid arthritis and mixed connective tissue disease. Chest 1998;113:1609-15.
63. 63 Rallenback J, Prinsloo I, Zwi S. Progressive systemic sclerosis complicated by diffuse pulmonary hemorrhage. Thorax 1977;32:767-70.
64. 64 Griffin MT, Robb JD, Martin JR. Diffuse alveolar hemorrhage associated with progressive systemic sclerosis. Thorax 1990;45:903-4.
65. 65 Csernok E, Ernst M, Schmitt W, et al. Activated neutrophils express proteinase 3 in their plasma membrane in vitro and in vivo. Clin Exp Immunol 1994;51:244-50.
66. 66 Brouwer E, Huitema MG, Mulder AHL, et al. Neutrophil activation in vitro and in vivo in Wegener's granulomatosis. Kidney Int 1994;45:1120-31.
67. 67 Hoffman GS, Specks V. Antineutrophil cytoplasmic antibodies. Arthritis Rheum 1998;41:1521-37.
68. 68 Kevil CG, Bullard DC. Roles of leucocyte/endothelial cell adhesion molecules in the pathogenesis of vasculitis. Am J Med 1999;106:677-87.
69. 69 Savage COS, Pottinger BE, Gaskin G, et al. Autoantibodies developing to myeloperoxidase and proteinase 3 in systemic vasculitis stimulate neutrophil cytotoxicity toward cultured endothelial cells. Am J Pathol 1992;141:335-42.
70. 70 Mayer WJ, Schwarting A, Meyer Zum Buschenfelde KH. Cytotoxic effect of antibodies to proteinase 3 (c-ANCA) on human endothelial cells. Clin Exp Immunol 1994;97:458-65.
71. 71 Tomer Y, Gilburg B, Blank M, et al. Characterization of biologically active antineutrophil cytoplasmic antibodies induced in mice. Pathogenetic role in experimental vasculitis. Arthritis Rheum 1995;38:1375-81.
72. 72 Blank M, Tomer Y, Stein M, et al. Immunization with antineutrophil cytoplasmic antibody (ANCA) in the production of mouse ANCA and perivascular lymphocyte infiltration. Clin Exp Immunol 1995;102:120-30.
73. 73 Jenne DE, Frohlich L, Hummel AM, et al. Cloning and functional expression of the murine homologue of proteinase 3: implications for the design of murine models of vasculitis. FEBS Lett 1997;408:187-90.
74. 74 Eagen JW, Memoli VA, Roberts JL, et al. Pulmonary hemorrhage in systemic lupus erythematosus. Medicine (Baltimore) 1978;57:545-60.
75. 75 Gertner E. Diffuse alveolar hemorrhage in the antiphospholipid syndrome: spectrum of disease and treatment. J Rheumatol 1999;26:805-7.
76. 76 Martinez JS, Kohler PF. Variant "Goodpasture's syndrome?" Ann Intern Med 1971;75:67-9.
77. 77 Della Rossa A, Trevisiani G, Bombardieri S. Cryoglobulins and cryoglobulinemia. Clin Rev Allergy Immunol 1998;249: 249-64.
78. 78 Clinicopathologic Conference. Proliferative glomerulonephritis and pulmonary hemorrhage. Am J Med 1973;55: 199-210.
79. 79 Lewis EJ, Schur PH, Busch GJ, et al. Immunologic features of a patient with glomerulonephritis and pulmonary hemorrhage. Am J Med 1973;54:507-13.
80. 80 Leatherman JW, Sibley RK, Davies SF. Diffuse intrapulmonary hemorrhage and glomerulonephritis unrelated to antiglomerular basement membrane antibody disease. Am J Med 1982;72:401-6.
81. 81 Kjellstrand CM, Simmons RL, Vranga VM, et al. Acute fulminant Wegener's granulomatosis: therapy with immunosuppression, hemodialysis and renal transplantation. Arch Intern Med 1974;34:40-3.
82. 82 Stokes TC, McCann BG, Rose RT, et al. Acute fulminating intrapulmonary hemorrhage in Wegener's granulomatosis. Thorax 1982;37:315-6.
83. 83 Travis WD, Carpenter HA, Lie ST. Diffuse pulmonary hemorrhage: an uncommon manifestation of Wegener's granulomatosis. Am J Surg Pathol 1987;11:702-8.
84. 84 Lendud C, DeVuyst RJ, Dupont E, et al. Wegener's granulomatosis presenting as acute respiratory failure with anti-neutrophil cytoplasm antibodies. Chest 1989;96:345-7.
85. 85 Travis WD, Hoffman GS, Leavitt RV, et al. Surgical pathology of the lung in Wegener's granulomatosis: a review of 87 open lung biopsies from 67 patients. Am J Surg Pathol 1991;15:315-33.
86. 86 Cordier JR, Valey RED, Buillevin L, et al. Pulmonary Wegener's granulomatosis: a clinical and imaging study of 77 cases. Chest 1990;97:906-12.
87. 87 Haworth SJ, Savage COS, Carr D, et al. Pulmonary hemorrhage complicating Wegener's granulomatosis and microscopic polyarteritis. BMJ 1985;290:1775-8.
88. 88 Brandwein S, Esdaile J, Danoff D, et al. Wegener's granulomatosis: clinical features and outcome in 13 patients. Arch Intern Med 1983;143:476-9.
89. 89 Sanchez-Masigues J, Ettensohn DB. Case report: alveolar hemorrhage in Wegener's granulomatosis. Am J Med Sci 1989;297:390-3.
90. 90 Case records of the Massachusetts General Hospital (case #25-1989). N Engl J Med 1989;320:1677-86.
91. 91 Yoshimura N, Matsubara O, Tamora A, et al. Wegener's granulomatosis associated with diffuse pulmonary hemorrhage. Acta Pathol Jpn 1992;42:637-57.
92. 92 Gaudin PB, Askin FB, Falk RJ, et al. The pathologic spectrum of pulmonary lesions in patients with antineutrophil cytoplasmic antibodies specific for antiproteinase 3 and antimyeloperoxidase. Am J Clin Pathol 1995;104: 7-16.
93. 93 Mignon F, Ronco PM. Necrotizing crescentic glomerulonephritis without significant immune deposits: a clinical and serological study. Q J Med 1993;86:55-68.
94. 94 Savige JA, Gallicchio M, Change L, et al. Autoantibodies in systemic vasculitis. Aust NZ J Med 1991;21:433-7.
95. 95 Niles JL, Bottinger EP, Saurina GR, et al. The syndrome of lung hemorrhage is usually an ANCA-associated condition. Arch Intern Med 1996;156:440-5.
96. 96 Gross WI, Luderman G, Krefer G, et al. Anticytoplasmic antibodies in Wegener's granulomatosis. Lancet 1986;i: 806.
97. 97 Andrasy K, Koderische J, Waldherr R, et al. Diagnostic significance of anticytoplasmic antibodies (ACPA/ANCA) in detection of Wegener's granulomatosis and other forms of systemic vasculitis. Nephron 1988;49:257-8.
98. 98 Falk RJ, Jennette JC. Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis. N Engl J Med 1988;318:1651-7.
99. 99 Goeken JA. Antineutrophil cytoplasmic antibody: a useful serologic marker for vasculitis. J Clin Immunol 1991;2:161-74.
100. 100 Case Records of the Massachusetts General Hospital (case #12-1986). N Engl J Med 1986;314:834-44.
101. 101 Hoffman GS, Kerr GS, Leavitt RY, et al. Wegener's granulomatosis: an analysis of 158 patients. Ann Intern Med 1992;116:488-98.
102. 102 Odeh M, Best LA, Kerner A, et al. Localized Wegener's granulomatosis relapsing as diffuse massive intra-alveolar hemorrhage. Chest 1993;104:955-6.
103. 103 Case records of the Massachusetts General Hospital (case #52-1993). N Engl J Med 1993;329:2019-26.
104. 104 Imoto EM, Lombard CM, Sachs DPI. Pulmonary capiliaritis and hemorrhage: a clue to the diagnosis of systemic necrotizing vasculitis. Chest 1989;96:927-8.
105. 105 Zashin S, Pator R, Fortin D. Microscopic polyarteritis: a forgotten etiology of hemoptyses and rapidly progressive glomerulonephritis. Ann Rheum Dis 1990;49:53-6.
106. 106 Doebbling BN, Bonsib SM, Walher WP. Pulmonary-renal syndrome with "triad" involvement due to small vessel vasculitis. J Rheumatol 1990;17:1087-90.
107. 107 Savage COS, Winearls CG, Evans DV, et al. Microscopic polyarteritis: presentation, pathology, and prognosis. Q J Med 1985;56:467-83.
108. 108 Bocanegra TS, Espinoza LR, Vasey FB, et al. Pulmonary hemorrhage in systemic necrotizing vasculitis associated with hepatitis B. Chest 1981;80:102-3.
109. 109 Sanchez M, Bosch X, Martinez C, et al. Idiopathic pulmonary-renal syndrome with antiproteinase 3 antibodies. Respiration 1994;61:295-9.
110. 110 Leaker B, Cambridge G, du Bois RM. Idiopathic pulmonary hemosiderosis: a form of microscopic polyarteritis. Thorax 1992;47:988-90.
111. 111 Niles JL, Bottinger EP, Saurina GR, et al. The syndrome of lung hemorrhage and nephritis is usually an ANCA-associated condition. Arch Intern Med 1996;156:440-5.
112. 112 Gaudin PB, Askin FB, Falk RJ, et al. The pathologic spectrum of pulmonary lesions in patients with anti-neutrophil cytoplasmic autoantibodies specific for proteinase 3 and myeloperoxidase. Am J Clin Pathol 1995;104:7-16.
113. 113 Maatem JC, Caspe FM, Franssen MD, et al. Respiratory failure in ANCA associated vasculitis. Chest 1996;110:357-62.
114. 114 Lhote F, Guillevi L. Polyarteritis nodosa, microscopic polyangiitis and Churg-Strauss syndrome. Semin Respir Crit Care Med 1998;19:27-45.
115. 115 Guillevi L, Durand-Gasselin B, Cevallosre T, et al. Microscopic polyangiitis: clinical and laboratory findings in 85 patients. Arthritis Rheum 1999;42:421-30.
116. 116 Hall JB, Wadham B, Wood CJ, et al. Vasculitis and glomerulonephritis: a subgroup with an antineutrophil antibody. Aust NZ J Med 1984;14:277-8.
117. 117 Thomashow BM, Felton CP, Navarrio C. Diffuse intrapulmonary hemorrhage, renal failure and a systemic vasculitis: a case report and review of the literature. Am J Med 1980; 68:299-304.
118. 118 Nada AR, Torres VE, Ryu JH, et al. Pulmonary fibrosis as an unusual clinical manifestation of a pulmonary-renal vasculitis in elderly patients. Mayo Clin Proc 1990;65:847-56.
119. 119 Menchaca JA, Boris G, Wilson CB. Pulmonary hemorrhage: unusual manifestations of systemic lupus erythematosus (SLE). Kidney Int 1976;10:505.
120. 120 Kuhn C. Systemic lupus erythematosus in a patient with ultrastructural lesions of the pulmonary capillaries previously reported in the review as due to idiopathic pulmonary hemosiderosis. Am Rev Respir Dis 1972;106:931-2.
121. 121 Marino CT, Pertschuk LP. Pulmonary hemorrhage in systemic lupus erythematosus. Arch Intern Med 1981;141: 201-3.
122. 122 Matthay RA, Schwarz MI, Petty TL, et al. Pulmonary manifestations of systemic lupus erythematosus: review of twelve cases of acute lupus pneumonitis. Medicine (Baltimore) 1975;54:397-404.
123. 123 Mintz G, Galindo LF, Fernandez-Diez J, et al. Acute massive pulmonary hemorrhage in systemic lupus erythematosus. J Rheumatol 1978;5:39-50.
124. 124 Onomura K, Nakata H, Tanaka Y, et al. Pulmonary hemorrhage in patients with systemic lupus erythematosus. J Thorac Imaging 1991;6:57-61.
125. 125 Schwab EP, Schumacher HR, Feundlich B, et al. Pulmonary alveolar hemorrhage in systemic lupus erythematosus. Semin Arthritis Rheum 1993;23:8-15.
126. 126 Carette S, Macher AM, Nussbaum A, et al. Severe, acute pulmonary disease in patients with systemic lupus erythematosus: ten years experience at the National Institutes of Health. Semin Arthritis Rheum 1984;14:52-9.
127. 127 Herman PG, Balikian JP, Seltzer SE, et al. The pulmonary renal syndrome. AJR 1979;119:1141-8.
128. 128 Millman RP, Cohen TB, Levinson AL, et al. Systemic lupus erythematosus complicated by acute pulmonary hemorrhage: recovery following plasmapheresis and cytotoxic therapy. J Rheumatol 1981;8:1021-3.
129. 129 Torralbo A, Herrero JA, Portoles J, et al. Alveolar hemorrhage associated with anti-neutrophil cytoplasmic antibodies in rheumatoid arthritis. Chest 1994;104:1590-2.
130. 130 Ognibene AJ, Dito WR. Rheumatoid disease with unusual pulmonary manifestations. Arch Intern Med 1966;116:567-70.
131. 131 Smith BS. Idiopathic pulmonary hemosiderosis and rheumatoid arthritis. BMJ 1966;1:1403-6.
132. 132 Naschitz JE, Yeshurun D, Scharf Y, et al. Recurrent massive alveolar hemorrhage, crescentic glomerulonephritis and necrotizing vasculitis in a patient with rheumatoid arthritis. Arch Intern Med 1989;149:406-8.
133. 133 Rallenback J, Prinsloo I, Zwi S. Progressive systemic sclerosis complicated by diffuse pulmonary hemorrhage. Thorax 1977;32:767-70.
134. 134 Griffin MT, Robb JD, Marti JR. Diffuse alveolar hemorrhage associated with progressive systemic sclerosis. Thorax 1990;45:903-4.
135. 135 Nishi K, Myou S, Ooka T, et al. Diffuse cutaneous systemic sclerosis associated with pan-scrositis, disseminated intravascular coagulation and diffuse alveolar hemorrhage. Respir Med 1994;88:471-3.
136. 136 Gertner E. Diffuse alveolar hemorrhage in the antiphospholipid syndrome: spectrum of disease and treatment. J Rheumatol 1999;26:805-7.
137. 137 Lynch JP III, McLune WJ. Immunosuppressive and cytotoxic pharmacotherapy for pulmonary disorders. Am J Respir Crit Care Med 1997;155:395-420.
138. 138 Hoffman GS, Kerr GS, Leavitt RY, et al. Wegener's granulomatosis: an analysis of 158 patients. Ann Intern Med 1992;116:488-98.
139. 131 Fauci AS, Haynes BF, Katz P, et al. Wegener's granulomatosus: prospective clinical and therapeutic experience with 85 patients for 21 years. Ann Intern Med 1983;98:76-85.
140. 140 Taylor HG, Smaata A. Treatment of vasculitis. Br J Clin Pharmacol 1993;35:93-104.
141. 141 Godeau B, Mainardi JL, Roudot-Thoraval F, et al. Factors associated with Pneumocystis carinii pneumonia in Wegener's granulomatosis. Ann Rheum Dis 1995;54:991-4.
142. 142 Ognibene F, Shelhamer JH, Hoffman GS, et al. Pneumocystis carinii pneumonia: a major complication of immunosuppressive therapy in patients with Wegener's granulomatosis. Am J Respir Crit Care Med 1995;151:795-9.
143. 143 Huynh DU, Gantenbein H, Binswanger U. Pneumocystis carinii pneumonia during immunosuppressive therapy for antineutrophil cytoplasmic autoantibody positive vasculitis. Arch Intern Med 1995;155:872-4.
144. 144 Talar-Williams C, Hijazi VM, McCellan M, et al. Cyclophosphamide-induced cystitis and bladder cancer in patients with Wegener's granulomatosis. Ann Intern Med 1996;124:477-84.
145. 145 Capizzi RL, Bertino JR, Methotrexate therpay of Wegener's granulomatosis. Ann Intern Med 1971;74:74-9.
146. 146 Sneller MC, Hoffman GW, Talar-Williams C, et al. An analysis of forty-two Wegener's granulomatosis patients treated with methotrexate and prednisone. Arthritis Rheum 1995;38:608-13.
147. 147 Rees AJ, Pusey C. Plasma exchange in systemic vasculitis. Neth J Med 1990;36:103-6.
148. 148 Lewis Ej, Hunsicker LG, Lan SP, et al. A controlled trial of plasmapheresis therapy in severe lupus nephritis. N Engl J Med 1992;326:1373-9.
149. 149 Lockwood CM, Rees AJ, Pearson TA, et al. Immunosuppression and plasma exchange in the treatment of Goodpasture's syndrome. Lancet 1976;i: 711-5.
150. 150 Keller F, Offerman G, Schultz EG, et al. Membrane plasma exchange in Goodpasture's syndrome. Am J Med 1984;287:32-6.
151. 151 Rosenblatt SG, Knight W, Bannayan GA, et al. Treatment of Goodpasture's syndrome with plasmapheresis. A case report and review of the literature. Am J Med 1979;66:689-96.
152. 152 Erickson SB, Kurtz SB, Donadio JV, et al. Use of combined plasmapheresis and immunosuppression in the treatment of Goodpasture's syndrome. Mayo Clin Proc 1979;54:714-20.
153. 153 Shumack KH, Rock GA. Therapeutic plasma exchange. N Engl J Med 1984;310:762-71.
154. 154 Erickson RW, Franklin WA, Emlen W. Treatment of hemorrhagic lupus pneumonitis with plasmapheresis. Semin Arthritis Rheum 1994;24:114-23.
155. 155 Euler HH, Guillevin L. Plasmapheresis and subsequent pulse cyclophosphamide in severe systemic lupus erythematosus. Ann Intern Med 1994;145:296-302.
156. 156 Jayne DR, Black CM, Davies M, et al. Treatment of systemic vasculitis with pooled intravenous immunoglobulin. Lancet 1991;337:1137-9.
157. 157 Jayne DR, Exnault V, Lockwood CM. ANCA anti-idiotype antibodies and the treatment of systemic vasculitis with intravenous immunoglobulin. J Autoimmunity 1993;6:207-19.
158. 158 Tuso P, Moudgil A, Hay J, et al. Treatment of antineutrophil cytoplasmic autoantibody-positive systemic vasculitis and glomerulonephritis with pooled intravenous gammaglobulin. Am J Kidney Dis 1992;30:504-8.
159. 159 Richter C, Schnabel A, Csernok E, et al. Treatment of Wegener's granulomatosis with intravenous immunoglobulin. Adv Exp Med Biol 1993;336:487-9.
160. 160 Pall AA, Varagunam M, Adu D, et al. Anti-idiotype activity against anti-mycloperoxidase antibodies in pooled human immunoglobulin. Clin Exp Immunol 1994;95:257-62.
161. 161 Lockwood CM, Thiru S, Steward S, et al. Treatment of refractory Wegener's granulomatosis with humanized monoclonal antibodies. Q J Med 1996;89:903-12.